Tender For supply of insulin degludec/insulin aspart (r-dna origin) solution for subcutaneous injection. 1 ml of the solution contains 100 units insulin degludec & insulin aspart (70% soluble insulin degludec and 30% soluble insulin aspart) equivalent to 2.56 mg salt-free anhydrous insulin degludec and 1.05 mg salt-free anhydrous insulin aspart in 3 ml prefilled pen